Trending
  • Microplastics in intravenous infusions: emerging health concerns for medical practitioners
  • Interval breast cancer: understanding risks and the need for enhanced screening
  • Prostate cancer and erectile function: NeuroSAFE technique enhances postoperative outcomes in robot-assisted radical prostatectomy
  • Sign Up for The Oncology Newsletter | Our free weekly news roundup
  • ESMO GI 2026: EMERALD trials paint mixed picture for TACE-immunotherapy combinations in hepatocellular carcinoma
  • Do breast cancer and irregular heartbeat have common risk factors and rates?
  • Vaccine against brain tumours shows promising long-term results
  • New brush test detects oral cancer in one hour
  • ESMO GI 2026: KRYSTAL-10 misses primary endpoints despite improved response rates in KRAS G12C-mutated metastatic colorectal cancer
  • Meta-analysis supports growing role of antibody-drug conjugates in advanced urothelial carcinoma
  • Patients favour mainstream breast cancer genetic testing delivered by treating specialists, Australian study finds
  • Telehealth palliative care coaching shows no overall benefit for caregivers of patients with advanced cancer
Oncology News Australia
Oncology News Australia
  • RSS
  • Facebook
  • Twitter
  • LinkedIn
Navigate
  • Featured
    • Cancer Drug News
    • Commentary
    • COVID-19 Pandemic
    • Digital Resources & Fundraising
    • Editor’s Choice
    • Events
    • Video
  • Podcasts
    • Beyond the Slide Diagnostics Series – Oncology Network Exclusive!
    • Cancer and COVID-19
    • Experts On Point
    • Supportive Care Matters with Prof. Bogda Koczwara AM
    • The Oncology Journal Club
    • The OJC Meets…
    • Women in Global Oncology
  • Focus
    • CAM
    • Cancer Nursing
    • Emerging Tech
    • Genetics
    • Geriatric Oncology
    • Haematology
    • Immunotherapy
    • Lifestyle, Nutrition & Environment
    • Medical Oncology
    • Paedatric Oncology & AYA
    • Palliative Care
    • Pathology & Diagnostics
    • Pharmacology
    • Psycho-oncology
    • Radiation Oncology and Nuclear Medicine
    • Surgical Oncology
    • Treatment and Support
    • Screening & Prevention
    • Survivorship and QoL
  • Tumour
    • Bone Cancer
    • Breast Cancer
    • GI Cancers
    • GU Cancers
    • Gynaecologic Cancers
    • Neuro-oncology, Head and Neck Cancers
    • Kidney Cancer
    • Leukaemia
    • Lung Cancer
    • Lymphoma
    • Melanoma and Skin Cancer
    • Myeloma
    • Pancreatic Cancer
    • Prostate Cancer
    • Rare Cancers
  • Industry
    • Company News Archive
    • Aethlon Medical Australia
    • Boehringer Ingelheim
    • BXTAccelyon
    • Celgene
    • Daiichi Sankyo Australia
    • Eisai Australia
    • GenesisCare
    • Merck
    • OncoBeta
    • Pierre Fabre
    • Roche
    • QBiotics
  • Contact
  • More
    • About Us
    • Our Authors
    • The Oncology Newsletter
  • Featured
    • Cancer Drug News
    • Commentary
    • COVID-19 Pandemic
    • Digital Resources & Fundraising
    • Editor’s Choice
    • Events
    • Video
  • Podcasts
    • Beyond the Slide Diagnostics Series – Oncology Network Exclusive!
    • Cancer and COVID-19
    • Experts On Point
    • Supportive Care Matters with Prof. Bogda Koczwara AM
    • The Oncology Journal Club
    • The OJC Meets…
    • Women in Global Oncology
  • Focus
    • CAM
    • Cancer Nursing
    • Emerging Tech
    • Genetics
    • Geriatric Oncology
    • Haematology
    • Immunotherapy
    • Lifestyle, Nutrition & Environment
    • Medical Oncology
    • Paedatric Oncology & AYA
    • Palliative Care
    • Pathology & Diagnostics
    • Pharmacology
    • Psycho-oncology
    • Radiation Oncology and Nuclear Medicine
    • Surgical Oncology
    • Treatment and Support
    • Screening & Prevention
    • Survivorship and QoL
  • Tumour
    • Bone Cancer
    • Breast Cancer
    • GI Cancers
    • GU Cancers
    • Gynaecologic Cancers
    • Neuro-oncology, Head and Neck Cancers
    • Kidney Cancer
    • Leukaemia
    • Lung Cancer
    • Lymphoma
    • Melanoma and Skin Cancer
    • Myeloma
    • Pancreatic Cancer
    • Prostate Cancer
    • Rare Cancers
  • Industry
    • Company News Archive
    • Aethlon Medical Australia
    • Boehringer Ingelheim
    • BXTAccelyon
    • Celgene
    • Daiichi Sankyo Australia
    • Eisai Australia
    • GenesisCare
    • Merck
    • OncoBeta
    • Pierre Fabre
    • Roche
    • QBiotics
  • Contact
  • More
    • About Us
    • Our Authors
    • The Oncology Newsletter
You are at:Home » Industry Spotlight » Category: "Daiichi Sankyo Australia"

Browsing: Daiichi Sankyo Australia

Nothing Found!

Apologies, but no results were found for the requested archive. Perhaps searching will help find a related post.

  • FEATURED EVENT: GI CANCER TRIALS ASM

  • LATEST PODCASTS

    June, 2026
    Jun 13 S4 E5: ASCO 2026 Special Part 2
    Jun 09 S4 E4: The Oncology Journal Club Podcast ASCO 2026 Special – Part 1
    May, 2026
    May 20 S4 E3:‘Mouthwatering’ RAS(ON), Bob Marley’s Melanoma, ADT Hot Flushes + Prostate Cancer Terminology
    April, 2026
    Apr 23 S4 E2: iCCA, Chrono-Oncology + Genomic Therapy Matching
    March, 2026
    Mar 11 S4 E1: Hot Flushes, Aspirin and AI
    December, 2025
    Dec 24 S3E11 The Oncology Journal Club: End of Year Special
    Dec 10 S3E10 The Oncology Journal Club: I am large, I contain multitudes!
    November, 2025
    Nov 06 S3 E9 The Oncology Journal Club ESMO 2025 Special: Part 2
    October, 2025
    Oct 28 S3E8 The Oncology Journal Club: ESMO 2025 Special Part 1
    Oct 16 AGITG ASM 2025: Special Podcast Preview
    September, 2025
    Sep 23 S3E7 The Oncology Journal Club
    August, 2025
    Aug 30 Season 2 – Episode 3: Getting Exercise to Improve Cancer Survival? Challenge Accepted!
  • About Us

    Oncology News Australia is a small group of publishing, media and digital professionals providing resources for the oncology community. More information.

  • Subscribe for News Updates

    The Oncology Newsletter is a free publication distributed to healthcare professionals every week, featuring news, views, reviews and the latest jobs. Subscribe.
  • Advertising with Us

    If you seek to connect and present your product or service to an engaged oncology healthcare community, you have come to the right place. More information.

ACKNOWLEDGEMENT OF COUNTRY

We respectfully acknowledge the Traditional Custodians of the land on which we operate and gather. We honour their deep and enduring connection to the land, waters and skies, and pay our respects to Elders past, present and emerging.

 

We recognise the invaluable contributions of Aboriginal and Torres Strait Islander peoples to the health and wellbeing of our community.  We acknowledge the significant disparities in health outcomes between Indigenous and non-Indigenous Australians and are devoted to playing our part in closing this gap. We pledge to continually learn from and with Aboriginal and Torres Strait Islander communities, striving for a future where health equity is a reality.

 

© 2024 Oncology News part of The Oncology Media Group | [email protected]